RBC Europe’s CytRx Corp CYTR Stock Holding History

RBC Europe’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-17	Closed	-$11	–	1113
2019 Q1	$11	Hold	17	–	–	﹤0.01%	1078
2018 Q4	$8	Hold	17	–	–	﹤0.01%	1091
2018 Q3	$18	Hold	17	–	–	﹤0.01%	1127
2018 Q2	$19	Hold	17	–	–	﹤0.01%	1137
2018 Q1	$27	Hold	17	–	–	﹤0.01%	1119
2017 Q4	$29	Hold	17	–	–	﹤0.01%	1129
2017 Q3	$41	Buy	+17	New	+$57	﹤0.01%	1129

Other funds holding CYTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CTA

Colonial Trust Advisors Spartanburg, South Carolina $1.29B AUM 19.9% 1-Year Est. Return

RBC Europe's CYTR Position: Q2 2019 in Review

RBC Europe sold out of CytRx Corp (CYTR) in Q2 2019, closing a stake of 17 shares — an estimated $11 sold.

RBC Europe first reported a position in CYTR in Q3 2017 and held it in 7 quarters. The position peaked at $41 in Q3 2017. 5 funds tracked by Wall St. Rank hold CYTR as of Q2 2019.

RBC Europe reported no remaining CytRx Corp position as of Q2 2019 after selling out during the quarter.
RBC Europe sold 17 CytRx Corp shares in Q2 2019, an estimated $11.
RBC Europe first reported a position in CytRx Corp in Q3 2017 and held it in 7 quarters.
RBC Europe's CytRx Corp position peaked at $41 in Q3 2017.
5 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2019.

Based on RBC Europe's 13F filing for Q2 2019, filed 9 Nov 2023.